Insider Trading & Ownership - Reasons Bryan M.

Real time insider trading transaction history:

  • Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Insider Trading Transactions for Reasons Bryan M.
Common stock purchase or sale:
Transaction
Date
Reported
DateTime
Company Symbol Insider
Relationship
Shares
Traded
Average
Price
Total
Amount
Shares
Owned
Filing
2024-04-08
Sale
2024-04-08
9:34 pm
Societal CDMO Inc. SCTL Reasons Bryan M.
Director
73,620 $1.1 $80,982 0
(Direct)
View
2023-11-14
Sale
2023-11-16
4:15 pm
Mallinckrodt plc MNKTQ Reasons Bryan M.
EVP & CFO
96,660 $0 $0 0
(Direct)
View
2023-08-28
Purchase
2023-08-28
4:32 pm
Societal CDMO Inc. SCTL Reasons Bryan M.
Director
62,500 $0.4 $25,000 291,049
(Direct)
View
2022-06-16
Sale
2022-06-21
6:23 pm
Mallinckrodt plc MNKPF Reasons Bryan M.
EVP & CFO
11,593 $0 $0 0
(Direct)
View
2020-12-03
Sale
2020-12-07
4:13 pm
Mallinckrodt plc MNKKQ Reasons Bryan M.
EVP & CFO
5,400 $0.165 $891 11,593
(Direct)
View

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date
Reported
DateTime
Exercisable
Expiration
Company Symnbol Insider
Relationship
Shares
Traded
Conversion
Price
Shares
Owned
Filing
2025-01-01
Exercise
2025-01-02
5:01 pm
N/A
N/A
Mallinckrodt plc Reasons Bryan M.
EVP & CFO
6,838 $0 18,793
(Direct)
View
2025-01-01
Tax Withholding
2025-01-02
5:01 pm
N/A
N/A
Mallinckrodt plc Reasons Bryan M.
EVP & CFO
1,724 $0 18,793
(Direct)
View
2024-06-01
Exercise
2024-06-04
4:30 pm
N/A
N/A
Aclaris Therapeutics Inc. ACRS Reasons Bryan M.
Director
4,660 $0 28,732
(Direct)
View
2024-04-08
Equity Swap
2024-04-08
9:34 pm
N/A
N/A
Societal CDMO Inc. SCTL Reasons Bryan M.
Director
217,429 $1.1 0
(Direct)
View
2024-02-02
Option Award
2024-02-06
4:31 pm
N/A
N/A
Mallinckrodt plc Reasons Bryan M.
EVP & CFO
20,517 $0 20,517
(Direct)
View
2023-08-17
Tax Withholding
2023-08-18
9:21 pm
N/A
N/A
Mallinckrodt plc MNK Reasons Bryan M.
EVP & CFO
15,976 $0.693 96,660
(Direct)
View
2023-06-02
Exercise
2023-06-05
4:57 pm
N/A
N/A
Aclaris Therapeutics Inc. ACRS Reasons Bryan M.
Director
4,507 $0 44,482
(Direct)
View
2023-06-01
Option Award
2023-06-05
4:57 pm
N/A
2033-05-31
Aclaris Therapeutics Inc. ACRS Reasons Bryan M.
Director
20,410 $0 44,482
(Direct)
View
2023-05-17
Option Award
2023-05-19
4:55 pm
N/A
2033-05-17
Societal CDMO Inc. SCTL Reasons Bryan M.
Director
100,849 $0 255,778
(Direct)
View
2023-04-03
Option Award
2023-04-05
7:06 pm
N/A
N/A
Mallinckrodt plc MNK Reasons Bryan M.
EVP & CFO
168,237 $0 168,237
(Direct)
View
2022-12-14
Option Award
2022-12-22
5:47 pm
N/A
N/A
Mallinckrodt plc MNK Reasons Bryan M.
EVP & CFO
112,636 $0 112,636
(Direct)
View
2022-06-03
Exercise
2022-06-06
5:33 pm
N/A
N/A
Aclaris Therapeutics Inc. ACRS Reasons Bryan M.
Director
3,356 $0 39,822
(Direct)
View
2022-06-02
Option Award
2022-06-06
5:33 pm
N/A
2032-06-01
Aclaris Therapeutics Inc. ACRS Reasons Bryan M.
Director
20,257 $0 39,822
(Direct)
View
2022-05-18
Option Award
2022-05-20
5:36 pm
N/A
2032-05-18
Societal CDMO Inc. SCTL Reasons Bryan M.
Director
205,682 $0 273,111
(Direct)
View
2021-06-03
Option Award
2021-06-04
8:09 pm
N/A
2031-06-02
Aclaris Therapeutics Inc. ACRS Reasons Bryan M.
Director
15,606 $0 15,606
(Direct)
View
2021-04-20
Option Award(A)
2021-05-17
4:03 pm
N/A
2031-04-20
Recro Pharma Inc. REPH Reasons Bryan M.
Director
38,012 $0 38,012
(Direct)
View
2021-04-20
Option Award
2021-04-22
5:58 pm
N/A
2031-04-20
Recro Pharma Inc. REPH Reasons Bryan M.
Director
64,935 $0 105,441
(Direct)
View
2020-06-06
Exercise
2020-06-08
5:46 pm
N/A
N/A
Aclaris Therapeutics Inc. ACRS Reasons Bryan M.
Director
7,333 $0 32,709
(Direct)
View
2020-06-04
Option Award
2020-06-08
5:46 pm
N/A
2030-06-03
Aclaris Therapeutics Inc. ACRS Reasons Bryan M.
Director
16,500 $0 32,709
(Direct)
View
2020-05-07
Option Award
2020-05-11
5:05 pm
N/A
2030-05-07
Recro Pharma Inc. REPH Reasons Bryan M.
Director
20,768 $0 52,911
(Direct)
View
(A) Indicate amendment filing.